1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "157-03-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-108357

    L-6-Diazo-5-oxonorleucine; DON

    Glutaminase Cancer Infection
    L-6-Diazo-5-oxonorleucine (L-6-Diazo-5-oxonorleucine) is a glutaminases antagonist with a Ki of 6 μM. L-6-Diazo-5-oxonorleucine exhibits analgesic, antibacterial, antiviral and anticancer properties. L-6-Diazo-5-oxonorleucine displays genetic toxicity in vitro. L-6-Diazo-5-oxonorleucine decreases the self-renewal potential and metastatic ability of tumor cell.